Alpha 2.0
Login Register
» Authors » J R Beshansky

J R Beshansky

Explore the profile of J R Beshansky including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 777
Followers 0
Related Specialties
General Medicine
Cardiology & Vascular Diseases
Pharmacology
Top 10 Co-Authors
H P Selker
J L Griffith
R B DAgostino
C Maynard
S G Pauker
M M Laks
C H Schmid
Y Zhou
K L Ellis
R M Califf
Published In
J Gen Intern Med
Pharmacogenomics J
Am J Cardiol
Med Decis Making
Ann Intern Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial
Ellis K, Zhou Y, Rodriguez-Murillo L, Beshansky J, Ainehsazan E, Selker H, et al.
Pharmacogenomics J . 2015 Dec; 17(1):76-83. PMID: 26644202
Glucose-insulin-potassium (GIK) therapy may promote a shift from oxygen-wasteful free fatty acid (FFA) metabolism to glycolysis, potentially reducing myocardial damage during ischemia. Genetic variation associated with FFA response to GIK...
2.
Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial
Ellis K, Zhou Y, Beshansky J, Ainehsazan E, Selker H, Cupples L, et al.
Pharmacogenomics J . 2015 Mar; 15(6):488-95. PMID: 25778467
Modifiers of response to glucose, insulin and potassium (GIK) infusion may affect clinical outcomes in acute coronary syndromes (ACS). In an Immediate Myocardial Metabolic Enhancement During Initial Assessment And Treatment...
3.
Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial
Ellis K, Zhou Y, Beshansky J, Ainehsazan E, Yang Y, Selker H, et al.
Pharmacogenomics J . 2014 Aug; 15(1):55-62. PMID: 25135348
The mechanistic effects of intravenous glucose, insulin and potassium (GIK) in cardiac ischemia are not well understood. We conducted a genetic sub-study of the Immediate Myocardial Metabolic Enhancement During Initial...
4.
Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial
Feldman J, Fish S, Beshansky J, Griffith J, Woolard R, Selker H
Ann Emerg Med . 2000 Oct; 36(5):469-76. PMID: 11054201
Study Objective: To describe the characteristics of a large group of patients who presented to emergency departments with cocaine-associated symptoms consistent with acute cardiac ischemia (ACI) and to determine the...
5.
Missed diagnoses of acute cardiac ischemia in the emergency department
Pope J, Aufderheide T, Ruthazer R, Woolard R, Feldman J, Beshansky J, et al.
N Engl J Med . 2000 Apr; 342(16):1163-70. PMID: 10770981
Background: Discharging patients with acute myocardial infarction or unstable angina from the emergency department because of missed diagnoses can have dire consequences. We studied the incidence of, factors related to,...
6.
Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial
Selker H, Beshansky J, Griffith J, Aufderheide T, Ballin D, Bernard S, et al.
Ann Intern Med . 1998 Dec; 129(11):845-55. PMID: 9867725
Background: Approximately 6 million U.S. patients present to emergency departments annually with symptoms suggesting acute cardiac ischemia. Triage decisions for these patients are important but remain difficult. Objective: To test...
7.
Insurance type and the transportation to emergency departments of patients with acute cardiac ischemia: the ACI-TIPI Trial Insurance Study
Picken H, Zucker D, Griffith J, Beshansky J, Selker H
Am J Manag Care . 1998 May; 4(6):821-7. PMID: 10181068
The relationship of insurance type to treatment-seeking behavior (ie, the transportation to emergency departments of patients with symptoms suggestive of acute cardiac ischemia) was evaluated. The focus was on comparing...
8.
A logistic regression model when some events precede treatment: the effect of thrombolytic therapy for acute myocardial infarction on the risk of cardiac arrest
Schmid C, DAgostino R, Griffith J, Beshansky J, Selker H
J Clin Epidemiol . 1997 Dec; 50(11):1219-29. PMID: 9393378
When outcomes occur in clinical trials before treatment can be given, neither intent-to-treat nor according-to-protocol analyses give optimal estimates of the treatment effect. A better approach employs a time-dependent variable...
9.
Causes of chest pain and symptoms suggestive of acute cardiac ischemia in African-American patients presenting to the emergency department: a multicenter study
Maynard C, Beshansky J, Griffith J, Selker H
J Natl Med Assoc . 1997 Nov; 89(10):665-71. PMID: 9347680
This study examines whether race is a significant determinant of the diagnoses of acute myocardial infarction or angina pectoris in patients with symptoms suggestive of acute cardiac ischemia. The study...
10.
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument
Selker H, Griffith J, Beshansky J, Schmid C, Califf R, DAgostino R, et al.
Ann Intern Med . 1997 Oct; 127(7):538-56. PMID: 9313022
Background: Thrombolytic therapy can be life-saving in patients with acute myocardial infarction. However, if given too late or insufficiently selectively, it may provide little benefit but still cause serious complications...